Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis

Mitchell, 2010, Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) – a 20-year review: can we do better?, Amyotroph Lateral Scler, 11, 537, 10.3109/17482968.2010.495158 Chen, 2013, Genetics of amyotrophic lateral sclerosis: an update, Mol Neurodegener, 8, 28, 10.1186/1750-1326-8-28 Johnson, 2010, Exome sequencing reveals VCP mutations as a cause of familial ALS, Neuron, 68, 857, 10.1016/j.neuron.2010.11.036 Heyn, 2012, DNA methylation profiling in the clinic: applications and challenges, Nat Rev Genet, 13, 679, 10.1038/nrg3270 Qureshi, 2013, Understanding neurological disease mechanisms in the era of epigenetics, JAMA Neurol, 70, 703, 10.1001/jamaneurol.2013.1443 Hunter, 2016, Epigenetic footprints for neurodegenerative and autoimmune conditions: a comparative analysis Sherman, 2011, Proposed BioRepository platform solution for the ALS research community, Amyotroph Lateral Scler, 12, 11, 10.3109/17482968.2010.539233 Bastonini, 2014, Chromatin barcodes as biomarkers for melanoma, Pigment Cell Melanoma Res, 27, 788, 10.1111/pcmr.12258 Carini, 2018, Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis, J Transl Med, 10.1186/s12967-018-1387-9 Jakub, 2015, A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma, Melanoma Res, 10.1097/CMR.0000000000000182 McCord, 2014, Chromatin signatures of DLBCL subtypes Salter, 2016, Epigenetic signatures and early detection of neurodegenerative diseases Sangurdekar, 2016, Chromosome conformation capture to discover candidate epigenetic markers of multiple sclerosis disease severity Crutchley, 2010, Chromatin conformation signatures: ideal human disease biomarkers?, Biomark Med, 4, 611, 10.2217/bmm.10.68 Chen, 2015, New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis, Transl Neurodegener, 4, 17, 10.1186/s40035-015-0040-2 Nguyen, 2018, Autophagy as a common pathway in amyotrophic lateral sclerosis, Neurosci Lett, 10.1016/j.neulet.2018.04.006 Su, 2014, Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research, Muscle Nerve, 49, 786, 10.1002/mus.24198 Vajda, 2017, Genetic testing in ALS: a survey of current practices, Neurology, 10.1212/WNL.0000000000003686 Lai, 2006, Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking, J Neurosci, 26, 11798, 10.1523/JNEUROSCI.2084-06.2006 Landers, 2009, Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis, Proc Natl Acad Sci U S A, 106, 9004, 10.1073/pnas.0812937106 van Doormaal, 2014, Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study, Neurobiol Aging, 35, 10.1016/j.neurobiolaging.2014.04.014 Bakkar, 2015, Use of biomarkers in ALS drug development and clinical trials, Brain Res, 10.1016/j.brainres.2014.10.031 Byrne, 2011, Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis, J Neurol Neurosurg Psychiatry, 82, 623, 10.1136/jnnp.2010.224501 Simon, 2014, Quantifying disease progression in amyotrophic lateral sclerosis, Ann Neurol, 10.1002/ana.24273 Traynor, 2004, Functional outcome measures as clinical trial endpoints in ALS, Neurology, 63, 1933, 10.1212/01.WNL.0000144345.49510.4E Debray, 2013, Frequency of C9Orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study, Neurobiol Aging, 34, 10.1016/j.neurobiolaging.2013.06.009 Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010 Dejesus-Hernandez, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011 Majounie, 2012, Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study, Lancet Neurol, 11, 323, 10.1016/S1474-4422(12)70043-1 Brites, 2014, Microglia centered pathogenesis in ALS: insights in cell interconnectivity, Front Cell Neurosci, 8, 10.3389/fncel.2014.00117 Miyamoto, 2016, Data supporting the role of Fyn in initiating myelination in the peripheral nervous system, Data Br, 7, 1098, 10.1016/j.dib.2016.03.096 Mihalas, 2015, IKK kinase assay for assessment of canonical NF-κB activation in neurons, Methods Mol Biol, 1280, 61, 10.1007/978-1-4939-2422-6_5 Lee, 2016, Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS, Exp Neurobiol, 25, 233, 10.5607/en.2016.25.5.233 Berry, 2018, Improved stratification of ALS clinical trials using predicted survival, Ann Clin Transl Neurol, 10.1002/acn3.550 Taylor, 2016, Predicting disease progression in amyotrophic lateral sclerosis, Ann Clin Transl Neurol, 10.1002/acn3.348 Julien, 2001, Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded, Cell, 10.1016/S0092-8674(01)00244-6 Bowerman, 2013, Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis, Front Cell Neurosci, 7, 214, 10.3389/fncel.2013.00214 Krieger, 1996, Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C, Trends Pharmacol Sci, 17, 114, 10.1016/0165-6147(96)10004-3 Lanius, 1995, A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis, J Neurochem, 65, 927, 10.1046/j.1471-4159.1995.65020927.x Battaglia, 2018, Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications, Curr Opin Pharmacol, 10.1016/j.coph.2018.02.007 Chiò, 2012, Global epidemiology of amyotrophic lateral sclerosis (ALS): a systematic review of the literature, Amyotroph Lateral Scler, 13, 126 Vu, 2017, Fluid-based biomarkers for amyotrophic lateral sclerosis, Neurotherapeutics, 10.1007/s13311-016-0503-x Marin, 2016, Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analyss, Int J Epidemiol, 10.1093/ije/dyw061 Roberts, 2016, Race/ethnicity, socioeconomic status, and ALS mortality in the United States, Neurology, 87, 2300, 10.1212/WNL.0000000000003298 Feinberg, 2018, The key role of epigenetics in human disease prevention and mitigation, N Engl J Med, 378, 1323, 10.1056/NEJMra1402513 Prattichizzo, 2017, Exosome-based immunomodulation during aging: a nano-perspective on inflamm-aging, Mech Ageing Dev, 10.1016/j.mad.2017.02.008 Ratajczak, 2016, Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later, Clin Transl Med, 10.1186/s40169-016-0087-4 Li, 2017, The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population, PLoS One, 12 Oeckl, 2016, Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS, Amyotroph Lateral Scler Front Degener, 17, 404, 10.3109/21678421.2016.1167913